First Hawaiian Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

First Hawaiian Bank’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,942	Closed	-$1.99M	–	748
2024 Q4	$1.99M	Buy	4,942 +836	+20%	+$388K	0.06%	225
2024 Q3	$1.91M	Buy	4,106 +784	+24%	+$377K	0.06%	249
2024 Q2	$1.56M	Sell	3,322 -320	-9%	-$139K	0.05%	270
2024 Q1	$1.52M	Sell	3,642 -785	-18%	-$332K	0.05%	297
2023 Q4	$1.8M	Buy	4,427 +563	+15%	+$208K	0.06%	256
2023 Q3	$1.34M	Sell	3,864 -229	-6%	-$80.1K	0.05%	304
2023 Q2	$1.44M	Sell	4,093 -1,817	-31%	-$612K	0.05%	293
2023 Q1	$1.86M	Sell	5,910 -123	-2%	-$36.9K	0.06%	233
2022 Q4	$1.74M	Sell	6,033 -91	-1%	-$27.7K	0.06%	236
2022 Q3	$1.77M	Buy	6,124 +558	+10%	+$161K	0.07%	207
2022 Q2	$1.57M	Buy	5,566 +2,769	+99%	+$741K	0.06%	248
2022 Q1	$730K	Hold	2,797	–	–	0.02%	482
2021 Q4	$614K	Buy	+2,797	New	+$544K	0.02%	556
2020 Q4	–	Sell	-6,379	Closed	-$1.74M	–	834
2020 Q3	$1.74M	Sell	6,379 -150	-2%	-$41.4K	0.09%	163
2020 Q2	$1.9M	Sell	6,529 -1,466	-18%	-$397K	0.1%	150
2020 Q1	$1.9M	Buy	7,995 +2,763	+53%	+$634K	0.12%	130
2019 Q4	$1.15M	Buy	5,232 +1,453	+38%	+$294K	0.05%	241
2019 Q3	$640K	Sell	3,779 -20	-0.5%	-$3.54K	0.03%	372
2019 Q2	$696K	Sell	3,799 -3,660	-49%	-$640K	0.04%	339
2019 Q1	$1.37M	Buy	7,459 +4,365	+141%	+$806K	0.07%	193
2018 Q4	$513K	Buy	3,094 +500	+19%	+$86.6K	0.03%	392
2018 Q3	$500K	Buy	+2,594	New	+$462K	0.03%	469
2013 Q3	–	Sell	-136	Closed	-$11K	–	503
2013 Q2	$11K	Buy	+136	New	+$10K	﹤0.01%	594

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

First Hawaiian Bank's VRTX Position: Q1 2025 in Review

First Hawaiian Bank sold out of Vertex Pharmaceuticals (VRTX) in Q1 2025, closing a stake of 4,942 shares — an estimated $1.99M sold.

First Hawaiian Bank first reported a position in VRTX in Q2 2013 and held it in 23 quarters. The position peaked at $1.99M in Q4 2024. 1,616 funds tracked by Wall St. Rank hold VRTX as of Q1 2025.

First Hawaiian Bank reported no remaining Vertex Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
First Hawaiian Bank sold 4,942 Vertex Pharmaceuticals shares in Q1 2025, an estimated $1.99M.
First Hawaiian Bank first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 23 quarters.
First Hawaiian Bank's Vertex Pharmaceuticals position peaked at $1.99M in Q4 2024.
1,616 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2025.

Based on First Hawaiian Bank's 13F filing for Q1 2025, filed 3 Apr 2025.